E-Book | March 17, 2021

Improving Diversity In Clinical Trials

Source: Life Science Leader

The lack of diversity in clinical trials isn’t a new problem, but in 2020 this issue rose to the forefront of the industry as a spotlight was cast on drug development as a whole due to the COVID pandemic. In fact, a key milestone related to this topic came in November 2020 when the FDA issued its final guidance, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs. The experts in this ebook come from varying backgrounds, and as such, offer a myriad of recommendations relating to improving clinical trial enrollment of racial and ethnic minority groups.

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader